作者:Chunhua Ma、Kang Jin、Jiangying Cao、Lei Zhang、Xiaoguang Li、Wenfang Xu
DOI:10.1016/j.bmc.2013.01.068
日期:2013.4
Aminopeptidase N (APN/CD13) over expressed on tumor cells, plays a critical role in tumor invasion, metastasis, and tumor angiogenesis. Here we described the design, synthesis and preliminary activity studies of novel leucine ureido derivatives as aminopeptidase N (APN/CD13) inhibitors. The results showed that compound 8c had the most potent inhibitory activity against APN with the IC50 value to 0
氨肽酶N(APN / CD13)在肿瘤细胞上过度表达,在肿瘤侵袭,转移和肿瘤血管生成中起关键作用。在这里,我们描述了新型亮氨酸脲基衍生物作为氨肽酶N(APN / CD13)抑制剂的设计,合成和初步活性研究。结果表明,化合物8c对APN的抑制作用最强,IC 50值为0.06±0.041μM,可用于进一步的抗癌药研究。